Remove authors matthew-berlin
article thumbnail

How about personalized medicine? Is the IP and Regulatory legal framework ready for this?

The IPKat

Furthermore: how does the legal system of marketing authorization and other regulatory rights apply to personalized medicines? The Speakers (in alphabetical order) Duncan Matthews is the former Director of the Queen Mary Intellectual Property Research Institute and a member of the Centre for Commercial Law Studies.